期刊文献+

恶性胰腺神经内分泌肿瘤的外科手术选择 被引量:6

Surgical treatment strategy for malignant pancreatic neuroendocrine tumor
原文传递
导出
摘要 目的 探讨恶性胰腺神经内分泌肿瘤(PENTs)外科手术方式选择的策略.方法 收集2003年1月至2009年12月收治的32例恶性PENTs患者的临床资料,其中男性19例,女性13例,年龄17~71岁,平均46.3岁.回顾性分析恶性PENTs患者的手术方式选择及预后情况.结果 32例恶性PENTs中,功能性PENTs 12例、无功能性PENTs 20例.31例行手术治疗,其中4例行肿瘤局部切除,7例行Whipple手术,17例行胰体尾联合脾切除术,3例行剖腹探查肿瘤活检术.1例经CT引导下穿刺活检病理证实为恶性PNETs后行保守治疗.2例患者随访18和19个月后失访,5例患者在术后1年内死亡,3例患者分别在术后14、26、49个月后死亡,22例术后平均随访28个月(4~83个月)仍然存活.生存分析结果显示,1、2、5年生存率分别为83.5%、72.6%、54.4%.结论 恶性PENTs应积极行手术治疗.胰头恶性PENTs是否行局部切除以及肿瘤减瘤手术尚有待进一步探讨. Objective To investigate the surgical options for the malignant pancreatic neuroendocrine tumor (PNETs). Methods The clinic data of 32 patients with malignant pancreatic neuroendocrine tumors who were admitted between January 2003 and December 2009 were summarized. There were 19 male and 13 female,aging from 17 to 71 years(mean age,46. 3 years). The general information,postoperative pathology results, surgical options and followup were also collected. Results There were 32 cases of malignant PNETs including functional malignant PNETs in 12 cases and nonfunctional malignant PNETs in 20 cases. Thirty-one patients accepted surgical treamtents which included local resections in 4 patients, Whipple procedures in 7 patients, distal pancreatectomy in 17 patients and laparotomy in 3 patients. One patient accepted CT guided biopsy. Follow up were lost in two patients after operations. Five patients died in the first year after operations. Twenty-two patients still survived after mean follow up of 28 months(4-83 months). The survival rate for this group of patients was 83.5% in the first year,72. 6% in the second year and 54. 4% in the fifth year. Conclusions Malignant PNETs is the proper indication for surgical treatments. More accumulation of clinical data is needed to evaluate the significance of local resection of malignant PNETs in pancreatic head and cytoreductive surgery.
出处 《中华外科杂志》 CAS CSCD 北大核心 2010年第18期1398-1401,共4页 Chinese Journal of Surgery
关键词 胰腺肿瘤 治疗 存活率 Pancreatic neoplasms Therapy Survival rate
  • 相关文献

参考文献18

  • 1Oberg K,Eriksson B.Endocrine tumours of the pancreas.Best Pract Res Clin Gastroenterol,2005,19:753-781.
  • 2Mantke R,Manger T,Schulz HU,et al.Multimodal treatment of euroendocrine tumors of the pancreas and the ampulla of vater.Dig Surg,1999,16:145-151.
  • 3Heitz PU,Komminoth P,Perrin A,et al.Pancreatic endocrine tumors:Introduction//DeLellis DA,Lloyd RV,Heitz PU,et al.eds.Pathology and Genetics of Tumours of Endocrine Organs.WHO Classification of Tumours.Lyon,France:IARC Press,2004:177-182.
  • 4Nguyen SQ,Angel LP,Divino CM,et al.Surgery in malignant pancreatic neuroendocrine tumors.J Surg Oncol,2007,96:397-403.
  • 5Dralle H,Krohn SL,Karges W,et al.Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors.World J Surg,2004,28:1248-1260.
  • 6Falconi M,Bettini R,Boninsegna L,et al.Surgical strategy in the treatment of pancreatic neuroendocrine tumors.JOP,2006,7:150-156.
  • 7Fendrich V,Langer P,Celik I,et al.An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors.Ann Surg,2006,244:845-851.
  • 8Bonney GK,G omez D,Rahman SH,et al.Results following surgical resection for malignant pancreatic neuroendocrine tumours.A single institutional experience.JOP,2008,9:19-25.
  • 9Hausman MS,Thompson NW,Gauger PG,et al.The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease.Surgery,2004,136:1205 -1211.
  • 10Norton JA.Endocrine tumours of the gastrointestinal tract:surgical treatment of neuroendocrine metastases.Best Pract Res Clin Gastroenterol,2005,19:577 -583.

同被引文献85

  • 1胡先贵,何天霖.功能性胰腺内分泌肿瘤的外科诊治[J].肝胆胰外科杂志,2006,18(1):1-3. 被引量:12
  • 2苗毅,郭峰,奚春华,徐泽宽,钱祝银,戴存才,刘训良,蒋奎荣,吴峻立.胰腺内分泌肿瘤的外科治疗[J].肝胆外科杂志,2007,15(3):168-171. 被引量:7
  • 3何天霖,胡先贵,张怡杰,刘瑞,邵成浩.胰腺神经内分泌肿瘤的外科诊治[J].中华普通外科杂志,2007,22(7):494-496. 被引量:3
  • 4An L, Li W, Yao KC. Assessment of contrast- enhanced ultrasonogra- phy in diagnosis and preoperative localization of insulinoma. Eur J Ra- diol,2011,80 (3) :675 - 80.
  • 5Yalcin S. Advances in the systemic treatment of pancreatic neuroendo- crine tumors. Cancer Treat Rev,2011,4,37 (2) : 127 - 32.
  • 6Pais SA ,A1- I4addad M, Mohamadnejad M, et al. EUS for pancreatic neuroendocrine tumors : a single-center, 11-year experience. Gastroi- ntest Endosc,2010,71 (7) : 1185 - 93.
  • 7Oberg KE, Reubi JC, Kwekkeboom D J, et al. Role of somatostatins in neuroendocrine tumor development and thera- py. Gastroenterology,2010,139 ( 3 ) :742 - 53.
  • 8La Rosa S, Klersy C, Uceella S, et al. Improved histologic and clini- copathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Patho1,2009,40 ( 1 ) :30 - 40.
  • 9石毅,孙跃明,苗毅,戴梦华,廖泉,赵玉沛.无功能胰腺神经内分泌癌的诊断与外科治疗[J].中国普通外科杂志,2007,16(10):939-942. 被引量:9
  • 10KLOPPEL G,PERREN A,HEITZ P U.The gastroenteropancreatic neuroendocrine cell system and its tumors:the WHO classification[J].Ann N Y Acad Sci,2004,1014:13-27.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部